BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 29924853)

  • 21. Results of a Treat-and-Eextend Regimen of Intravitreal Ranibizumab Injection for Macular Edema due to Branch Retinal Vein Occlusion.
    Hosogi M; Morizane Y; Shiode Y; Doi S; Kumase F; Kimura S; Hosokawa M; Hirano M; Toshima S; Takahashi K; Fujiwara A; Shiraga F
    Acta Med Okayama; 2018 Feb; 72(1):39-45. PubMed ID: 29463937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EVALUATION OF MACULAR ISCHEMIA IN EYES WITH BRANCH RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study.
    Kadomoto S; Muraoka Y; Ooto S; Miwa Y; Iida Y; Suzuma K; Murakami T; Ghashut R; Tsujikawa A; Yoshimura N
    Retina; 2018 Feb; 38(2):272-282. PubMed ID: 28221256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
    Kim M; Jeong S; Sagong M
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of anti-VEGF results between non-ischemic branch retinal vein occlusion and ischemic branch retinal vein occlusion with early sector panretinal photocoagulation.
    Akdemir SC; Gunay BO
    J Fr Ophtalmol; 2022 Nov; 45(9):1042-1047. PubMed ID: 36127168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of the first 12 months treatment of macular edema complicating BRVO in patients treated with ranibizumab.
    Lalinská L; Krásný J; Studený P; Veith M
    Cesk Slov Oftalmol; 2018; 74(2):62-67. PubMed ID: 30441951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion: 12-month results.
    Nishimura T; Machida S; Tada A; Oshida E; Muto T
    Doc Ophthalmol; 2020 Oct; 141(2):127-136. PubMed ID: 32100140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
    Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
    Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collateral Vessel Development in Central and Branch Retinal Vein Occlusions Are Associated With Worse Visual and Anatomic Outcomes.
    Arrigo A; Aragona E; Lattanzio R; Scalia G; Bandello F; Parodi MB
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):1. PubMed ID: 34724540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative Analysis of Retinal Microvascular Changes after Conbercept Therapy in Branch Retinal Vein Occlusion Using Optical Coherence Tomography Angiography.
    Deng Y; Cai X; Zhang S; Su L; Chen H; Lin Y; Sun L; Chen G; Zhong L; Jin C; Chi W
    Ophthalmologica; 2019; 242(2):69-80. PubMed ID: 31112969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of good visual acuity over time in patients with branch retinal vein occlusion with macular edema using support vector machine.
    Matsui Y; Imamura K; Ooka M; Chujo S; Mase Y; Matsubara H; Kawanaka H; Kondo M
    Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1501-1508. PubMed ID: 34773490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy.
    Suzuki M; Nagai N; Minami S; Kurihara T; Kamoshita M; Sonobe H; Watanabe K; Shinoda H; Tsubota K; Ozawa Y
    Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):49-56. PubMed ID: 31732812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macular dynamics and visual acuity prognosis in retinal vein occlusions - ways to connect.
    Dărăbuș DM; Pac CP; Roşca C; Munteanu M
    Rom J Ophthalmol; 2023; 67(3):312-324. PubMed ID: 37876516
    [No Abstract]   [Full Text] [Related]  

  • 33. Healing rate of macular edema secondary to branch retinal vein occlusion in two years after initiation of intravitreal ranibizumab later combined with other treatment as needed and characteristics of refractory cases.
    Kawakami S; Wakabayashi Y; Watanabe Y; Umazume K; Yamamoto K; Goto H
    PLoS One; 2023; 18(1):e0278968. PubMed ID: 36595494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aniseikonia following intravitreal ranibizumab treatment for branch retinal vein occlusion.
    Morikawa S; Okamoto F; Murakami T; Sugiura Y; Hiraoka T; Oshika T
    Jpn J Ophthalmol; 2021 Sep; 65(5):672-679. PubMed ID: 34250549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema: Central Subfield Thickness and Ellipsoid Zone Analysis.
    Ciulla TA; Kapik B; Grewal DS; Ip MS
    Ophthalmol Retina; 2021 Jul; 5(7):633-647. PubMed ID: 33130256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment.
    Parodi MB; Iacono P; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1647-51. PubMed ID: 25382074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of leaking capillaries and microaneurysms in the perifoveal capillary network on resolution of macular edema by anti-vascular endothelial growth factor treatment.
    Iesato Y; Imai A; Hirano T; Toriyama Y; Murata T
    Jpn J Ophthalmol; 2016 Mar; 60(2):86-94. PubMed ID: 26801502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Retinal Microvasculature and Visual Acuity After Antivascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion.
    Winegarner A; Wakabayashi T; Fukushima Y; Sato T; Hara-Ueno C; Busch C; Nishiyama I; Shiraki N; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2708-2716. PubMed ID: 29860457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
    Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
    Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of retinal microvasculature and neurodegeneration changes in branch retinal vein occlusion after resolution of cystoid macular edema on optical coherence tomography angiography.
    Brar M; Sharma M; Grewal SPS; Grewal DS
    Indian J Ophthalmol; 2019 Nov; 67(11):1864-1869. PubMed ID: 31638051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.